Education
Her Cancer Journey Has Relied on Faith, Family and Fortitude
5 min. read
Baptist Health Miami Cancer Institute
Elizabeth Ferrara, a successful business owner, wife, mother and grandmother, has always been a workaholic. At one time, she owned three hair salons, a testament to her love for her craft. “I always told my kids, if you love what you’re doing, it’s not a job,” she says.
That passion, coupled with a healthy lifestyle of daily exercise and good nutrition, made her 2022 lung cancer diagnosis all the more shocking. “I couldn’t believe it because I was so healthy. I never smoked. I never drank,” Ms. Ferrara states, adding that the last time she was in a hospital was when she had her now-32-year-old daughter.
That diagnosis was only the beginning of a long and arduous health journey for Ms. Ferrara, who faced another devastating blow in August 2025. After feeling short of breath, she was diagnosed with two different types of blood cancer — acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Tests Reveal More Bad News
Complicating matters even more, genetic testing also revealed a TP53 mutation in Ms. Ferrara’s leukemia cells, classifying her disease as “adverse risk.” TP53 mutations are among the most common mutations in human cancers.
In myelodysplastic syndrome (MDS) or leukemia, a TP53 mutation is important because it usually means the disease may be more aggressive and may respond less well to some standard treatments, according to Firas El Chaer, M.D., chief of leukemia at Baptist Health Miami Cancer Institute.
“TP53 is a bad player in any cancer,” he says. “In acute myeloid leukemia, it comes with a bad prognosis and less likelihood to respond to chemotherapy.”
A ‘Particularly Challenging’ Case
Ms. Ferrara was admitted to Baptist Hospital, quite ill, to begin treatment under the care of Dr. El Chaer. Her case was particularly challenging, he says.
According to Dr. El Chaer, blood cancers such as AML and MDS can sometimes develop years after chemotherapy for another cancer.
“The two most common blood cancers that can happen because of a previous cancer treated with chemotherapy are AML and MDS,” says Dr. El Chaer. Being diagnosed with both AML and MDS at the same time makes treatment even more of a challenge, he adds.
At one point, Ms. Ferrara was told she might only have a few months to live. Her ongoing chemotherapy for her lung cancer was stopped so doctors could focus on the more immediate threat posed by the blood cancers.
Controlling Her MDS and AML
Ms. Ferrara’s initial treatment, called induction chemotherapy, was grueling. She spent 30 days in the hospital, battling infections, bleeding and fevers. “We were working very hard not to lose the patient to the infection and the chemotherapy,” Dr. El Chaer recalls.
In the past few decades, for patients with AML, there were very few treatment options and those options were quite toxic, Dr. El Chaer says. In the past ten years, however, great progress has been made treating the disease, using something called intermediate dose chemotherapy, which he calls a “lighter form of chemotherapy.”
Against the odds, Ms. Ferrara’s body responded to the treatment. “Her leukemia has remarkably responded to chemotherapy,” says Dr. El Chaer. “Even after the first cycle, her disease went into remission.”
Although her leukemia is in remission, Ms. Ferrara’s MDS and AML are considered incurable. The focus of her care has shifted from cure to control. The goal is to manage the disease and provide her with the best possible quality of life, for as long as possible.
“In cases where cure is not achievable, disease control with preservation of quality of life remains a worthy and realistic treatment goal,” Dr. El Chaer observes.
“Now we have targeted therapies — most of which are oral pills targeting specific cancer mutations — that can extend one’s life and provide a good quality of life,” Dr. El Chaer adds. “In Elizabeth’s case, she takes two pills a month at home and doesn’t even have to come in for intravenous infusions, which means more time for her to be where she wants to be — spending time with her family and at her church.”
A Powerful Foundation for Healing
Through it all, Ms. Ferrara’s family has been her rock. Her husband of 40 years, Matthew, is a constant presence by her side. Her daughter, Jamie, a pediatric anesthesiologist in Los Angeles, serves as a dedicated patient advocate, attending every appointment either in person or by phone.
“I have a big support system in my family,” Ms. Ferrara admits. “I am very blessed to have a daughter like her.”
Central to her resilience is her profound spiritual strength. “That’s how I survive — with the help of the Lord,” Ms. Ferrara shares. “God is the most important thing in our lives.”
This faith, combined with a positive mindset and the love of her family, created a powerful foundation for her healing. Dr. El Chaer notes the importance of this support, stating, “Having family close by is an important part of the journey.”
Embracing Life with Gratitude
Today, Ms. Ferrara is approaching life one day at a time, deeply appreciative of the extra time she has been given and enjoying every moment with her husband, three children and two grandchildren.
Her cancer journey has been defined by the exemplary care she received at Miami Cancer Institute and the strength she draws from her faith and family. Ms. Ferrara calls herself a “fighter” who is sustained by her deep faith and an unwavering support system.
Of her cancer burden, she says with absolute conviction, “I know I can carry it, and God is with me 100 percent.” And so are the doctors and nurses at Miami Cancer Institute, who she calls “the best of the best.”
For Dr. El Chaer, who was inspired to become a cancer physician after his own father’s battle with a blood cancer, seeing a patient like Ms. Ferrara survive against all odds is profoundly rewarding.
“She comes in for her monthly check-ups full of life and energy,” he says. “When you’re able to save a life, it’s very humbling,” he says.
Ms. Ferrara’s story is a powerful reminder that even in the face of a difficult prognosis, there can be hope, quality of life and precious time.
Click here for more information about the blood cancer services and specialists available at Baptist Health Miami Cancer Institute.
Featured Provider
Firas El Chaer, MD
Firas El Chaer, M.D., MSHCM, is a board-certified hematologist-oncologist and the chief of Leukemia and medical director of Infusion Services at Baptist Health Miami Cancer Institute. He specializes in the treatment of leukemia, with a primary focus on acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelomonocytic leukemia and chronic myeloid leukemia. His expertise also extends to myeloproliferative neoplasms (primary myelofibrosis, essential thrombocytosis and polycythemia vera), clonal hematopoiesis of indeterminate potential as well as bone marrow failure disorders, including myelodysplastic syndromes and aplastic anemia.
Dr. El Chaer utilizes personalized, targeted therapies to enhance treatment effectiveness and improve patient responses. Additionally, he has a keen interest in measurable residual disease detection and monitoring, which can improve patients’ long-term outcomes and survival rates by catching early signs of relapse so treatments and adjusting treatments accordingly.
Prior to joining Baptist Health, Dr. El Chaer was an associate professor of medicine in the Division of Hematology-Oncology at the University of Virginia School of Medicine. He also served as medical director of the Cancer Service Line – Infusion Centers and medical director of the Chronic and Acute Leukemia Research Team at the University of Virginia Comprehensive Cancer Center.
Dr. El Chaer earned his medical degree at the University of Balamand in Beirut, Lebanon. He served as chief resident during an internal medicine residency at the Icahn School of Medicine at Mount Sinai in Englewood, N.J. He then completed a fellowship in infectious diseases for immune-compromised cancer patients at the combined program of Baylor College of Medicine and the University of Texas at MD Anderson Cancer Center in Houston. He also completed a fellowship in hematology and oncology with a focus on blood disorders and a built-in fellowship in stem cell transplantation at the University of Maryland School of Medicine in Baltimore, where he served as chief fellow. He is board certified by the American Board of Internal Medicine in internal medicine, infectious diseases, hematology and medical oncology.
In addition to his patient care responsibilities, Dr. El Chaer is a clinical investigator and principal investigator for numerous pharmaceutical-sponsored clinical trials and investigator-initiated trials. He has been recognized with multiple awards across different areas of professional practice, including his clinical skills, research contributions and teaching abilities. One such award is the prestigious Arnold P. Gold Foundation Humanism in Medicine Award, which honors mentors who demonstrate care and compassion in the teaching and advising of medical students.
Dr. El Chaer is an active member of numerous professional organizations. He also contributes to the scientific community by presenting his research findings at national and international symposiums, editing and reviewing papers for medical publications and publishing his research in peer-reviewed journals, with more than 50 articles appearing in prominent journals such as Blood and JAMA Oncology.
Dr. El Chaer’s approach to patient care is deeply rooted in his personal experience, having witnessed the profound impact of non-Hodgkin lymphoma on his father and family. He prioritizes clear, compassionate communication and strives to connect with his patients and their families on a personal level, not only addressing medical needs but also serving as a supportive guide through each step of the cancer journey. His goal is to provide care that is as personal as it is professional, creating a support system that goes beyond traditional treatment.
Dr. El Chaer is fluent in English, French and Arabic. In his free time, he enjoys backpacking and road cycling and pushing his limits with CrossFit. He finds relaxation in listening to audiobooks and podcasts and seeks adventure by traveling to new countries and immersing himself in diverse cultures, exploring rich histories and discovering unique cuisines. This blend of physical and intellectual pursuits helps Dr. El Chaer recharge and stay inspired.
Leading the Way in Cancer Care and Research
Related Stories
View All Articles
Advanced Cancer Care Now Close to Home for Key West Community
March 19, 2026
2 min. read
Video